<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peripheral blood CD3+, CD19+, CD4+, CD8+ and CD45RO+ mononuclear cell subsets, T-cell proliferative responses to combinations of coimmobilized OKT3 antibody and an ECM protein (collagen I, collagen IV, fibronectin or elastin), and T-cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to collagen IV, fibronectin and elastin were studied in patients with aneurysmal <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>No significant difference was found in the major lymphocyte subsets between <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> patients receiving no <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> for <z:hpo ids='HP_0002181'>brain oedema</z:hpo> treatment and healthy blood donors </plain></SENT>
<SENT sid="2" pm="."><plain>Compared with the latter, both the <z:chebi fb="0" ids="41879">dexamethasone</z:chebi>-untreated and -treated <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> patients showed decreased relative proliferative responses of circulating T cells to OKT3 combinations with collagen IV and fibronectin, and an increased PHA-activated T-cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to elastin </plain></SENT>
<SENT sid="3" pm="."><plain>CD45RO+, CD4+ and CD19+ peripheral blood cell subsets, CD4+/CD8+ cell ratio, PHA-activated T-cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to fibronectin and collagen IV, and OKT3-triggered T-cell costimulatory responses to elastin, collagen IV and fibronectin were significantly higher in <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> patients presenting with delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> (DCV) than in their DCV-free counterparts </plain></SENT>
<SENT sid="4" pm="."><plain>The DCV-related differences in circulating lymphocyte subsets showed no apparent relationship to the <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> treatment, whereas the differences in the other indices were confined to the <z:chebi fb="0" ids="41879">dexamethasone</z:chebi>-untreated <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> patients </plain></SENT>
<SENT sid="5" pm="."><plain>The above results suggest that the CD4+/CD8+ ratio and T cell-ECM interactions play a role in the emergence of <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo>/DCV and may represent potential targets for <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> therapy </plain></SENT>
</text></document>